228 related articles for article (PubMed ID: 23667741)
21. Unresponsiveness to glibenclamide during chronic treatment induced by reduction of ATP-sensitive K+ channel activity.
Kawaki J; Nagashima K; Tanaka J; Miki T; Miyazaki M; Gonoi T; Mitsuhashi N; Nakajima N; Iwanaga T; Yano H; Seino S
Diabetes; 1999 Oct; 48(10):2001-6. PubMed ID: 10512365
[TBL] [Abstract][Full Text] [Related]
22. Influence of diabetic state and that of different sulfonylureas on the size of myocardial infarction with and without ischemic preconditioning in rabbits.
Nieszner E; Posa I; Kocsis E; Pogátsa G; Préda I; Koltai MZ
Exp Clin Endocrinol Diabetes; 2002 Aug; 110(5):212-8. PubMed ID: 12148084
[TBL] [Abstract][Full Text] [Related]
23. Glibenclamide Administration Attenuates Infarct Volume, Hemispheric Swelling, and Functional Impairments following Permanent Focal Cerebral Ischemia in Rats.
Wali B; Ishrat T; Atif F; Hua F; Stein DG; Sayeed I
Stroke Res Treat; 2012; 2012():460909. PubMed ID: 22988544
[TBL] [Abstract][Full Text] [Related]
24. SUR1-TRPM4 channel activation and phasic secretion of MMP-9 induced by tPA in brain endothelial cells.
Gerzanich V; Kwon MS; Woo SK; Ivanov A; Simard JM
PLoS One; 2018; 13(4):e0195526. PubMed ID: 29617457
[TBL] [Abstract][Full Text] [Related]
25. Influence of glibenclamide on outcome in patients with type 2 diabetes and traumatic brain injury.
Ding J; Yuan F; Guo JY; Chen H; Tian HL
Clin Neurol Neurosurg; 2013 Oct; 115(10):2166-9. PubMed ID: 23998719
[TBL] [Abstract][Full Text] [Related]
26. Endothelial sulfonylurea receptor 1-regulated NC Ca-ATP channels mediate progressive hemorrhagic necrosis following spinal cord injury.
Simard JM; Tsymbalyuk O; Ivanov A; Ivanova S; Bhatta S; Geng Z; Woo SK; Gerzanich V
J Clin Invest; 2007 Aug; 117(8):2105-13. PubMed ID: 17657312
[TBL] [Abstract][Full Text] [Related]
27. Profile of intravenous glyburide for the prevention of cerebral edema following large hemispheric infarction: evidence to date.
King ZA; Sheth KN; Kimberly WT; Simard JM
Drug Des Devel Ther; 2018; 12():2539-2552. PubMed ID: 30147301
[TBL] [Abstract][Full Text] [Related]
28. Glibenclamide enhances neurogenesis and improves long-term functional recovery after transient focal cerebral ischemia.
Ortega FJ; Jolkkonen J; Mahy N; Rodríguez MJ
J Cereb Blood Flow Metab; 2013 Mar; 33(3):356-64. PubMed ID: 23149556
[TBL] [Abstract][Full Text] [Related]
29. Glibenclamide, a Sur1-Trpm4 antagonist, does not improve outcome after collagenase-induced intracerebral hemorrhage.
Wilkinson CM; Brar PS; Balay CJ; Colbourne F
PLoS One; 2019; 14(5):e0215952. PubMed ID: 31042750
[TBL] [Abstract][Full Text] [Related]
30. Glibenclamide improves neurological function in neonatal hypoxia-ischemia in rats.
Zhou Y; Fathali N; Lekic T; Tang J; Zhang JH
Brain Res; 2009 May; 1270():131-9. PubMed ID: 19306849
[TBL] [Abstract][Full Text] [Related]
31. Salutary effects of glibenclamide during the chronic phase of murine experimental autoimmune encephalomyelitis.
Gerzanich V; Makar TK; Guda PR; Kwon MS; Stokum JA; Woo SK; Ivanova S; Ivanov A; Mehta RI; Morris AB; Bryan J; Bever CT; Simard JM
J Neuroinflammation; 2017 Sep; 14(1):177. PubMed ID: 28865458
[TBL] [Abstract][Full Text] [Related]
32. Prenatal infection decreases calbindin, decreases Purkinje cell volume and density and produces long-term motor deficits in Sprague-Dawley rats.
Wallace K; Veerisetty S; Paul I; May W; Miguel-Hidalgo JJ; Bennett W
Dev Neurosci; 2010; 32(4):302-12. PubMed ID: 20948182
[TBL] [Abstract][Full Text] [Related]
33. Neuroprotection in a rabbit model of intraventricular haemorrhage by cyclooxygenase-2, prostanoid receptor-1 or tumour necrosis factor-alpha inhibition.
Vinukonda G; Csiszar A; Hu F; Dummula K; Pandey NK; Zia MT; Ferreri NR; Ungvari Z; LaGamma EF; Ballabh P
Brain; 2010 Aug; 133(Pt 8):2264-80. PubMed ID: 20488889
[TBL] [Abstract][Full Text] [Related]
34. Vasoconstriction in telencephalic microvessels: a response to one model for intraventricular hemorrhage in beagle pups.
Leuschen MP; Nelson RM
Anat Rec; 1989 Aug; 224(4):534-40. PubMed ID: 2782633
[TBL] [Abstract][Full Text] [Related]
35. Role of Sulfonylurea Receptor 1 and Glibenclamide in Traumatic Brain Injury: A Review of the Evidence.
Jha RM; Bell J; Citerio G; Hemphill JC; Kimberly WT; Narayan RK; Sahuquillo J; Sheth KN; Simard JM
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936452
[TBL] [Abstract][Full Text] [Related]
36. Hepatic and associated response of rats to pregnancy, lactation and simultaneous treatment with butylated hydroxytoluene.
McFarlane M; Price SC; Cottrell S; Grasso P; Bremmer JN; Bomhard EM; Hinton RH
Food Chem Toxicol; 1997 Aug; 35(8):753-67. PubMed ID: 9350220
[TBL] [Abstract][Full Text] [Related]
37. Reduction in incidence of periventricular, intraventricular hemorrhages in hypertensive newborn beagles pretreated with phenobarbital.
Goddard-Finegold J; Armstrong DL
Pediatrics; 1987 Jun; 79(6):901-6. PubMed ID: 3588144
[TBL] [Abstract][Full Text] [Related]
38. Glibenclamide-induced apoptosis is specifically enhanced by expression of the sulfonylurea receptor isoform SUR1 but not by expression of SUR2B or the mutant SUR1(M1289T).
Hambrock A; de Oliveira Franz CB; Hiller S; Osswald H
J Pharmacol Exp Ther; 2006 Mar; 316(3):1031-7. PubMed ID: 16306272
[TBL] [Abstract][Full Text] [Related]
39. NTP toxicity report of reproductive dose range-finding study of Genistein (CAS No. 446-72-0) administered in feed to Sprague-Dawley rats.
Delclos KB; Newbold R
Toxic Rep Ser; 2007 Nov; (79):1-C2. PubMed ID: 18685712
[TBL] [Abstract][Full Text] [Related]
40. Glibenclamide and Therapeutic Hypothermia Have Comparable Effect on Attenuating Global Cerebral Edema Following Experimental Cardiac Arrest.
Nakayama S; Taguchi N; Isaka Y; Nakamura T; Tanaka M
Neurocrit Care; 2018 Aug; 29(1):119-127. PubMed ID: 29150777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
